Pharmaceuticals
* Drug maker Gilead Sciences Inc. of Foster City, Calif., and Royalty Pharma of New York agreed to pay Emory University $525 million to buy royalty rights to HIV drug emtricitabine, also known as Emtriva.
* Drug maker Gilead Sciences Inc. of Foster City, Calif., and Royalty Pharma of New York agreed to pay Emory University $525 million to buy royalty rights to HIV drug emtricitabine, also known as Emtriva.
